Resumen
Perinatal Hemolytic Disease is uncommon today due to its prevention. However, there are cases of highly sensitized mothers who wish to have a child, that forces this desired pregnancy to be controlled in a special way and be subjected to invasive procedures not exempt from fetal morbidity and mortality. Prenatal use of human inmunoglobulin in the mother may represent a therapeutic alternative. We present a case in which its use prevented the development of intrauterine disease and favored a good neonatal evolution despite the fact that the initial prognosis was very adverse.
| Título traducido de la contribución | Prevention of severe perinatal hemolytic disease with intravenous immunoglobulin in a highly sensitized patient |
|---|---|
| Idioma original | Español |
| Páginas (desde-hasta) | 76-80 |
| Número de páginas | 5 |
| Publicación | Revista Chilena de Obstetricia y Ginecologia |
| Volumen | 86 |
| N.º | 1 |
| DOI | |
| Estado | Publicada - feb. 2021 |
Nota bibliográfica
Publisher Copyright:© 2021 Sociedad Chilena de Obstetricia y Ginecologia. All rights reserved.
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
ODS 3: Salud y bienestar
Palabras clave
- Cordocentesis
- Immunoglobulin
- Intrauterine transfusion
- Perinatal hemolytic disease
- Rh(D) isoinmmunization
Huella
Profundice en los temas de investigación de 'Prevención de enfermedad hemolítica perinatal severa con inmunoglobulina intravenosa en paciente altamente sensibilizada'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver